Drug prices are on the move upward once again in 2020, according to new data from 3 Axis Advisors.

Hospital acquisitions may have a negative impact on the quality of patient care, according to new findings published in the New England Journal of Medicine. The study results may help answer the question of how mergers and acquisitions impact patients and quality of care.

Some legislators had hoped to enact a legislative remedy to this problem in 2019, with it drawing ire from politicians in both parties. 

The American College of Radiology revoked Radiology Disc of Encino’s accreditation after it did not pass a mandatory inspection under the Mammography Quality Standards Act.

President Trump signed the latest $1.4 trillion spending bills into law to fund the government and simultaneously gutted three taxes related to the Affordable Care Act: the health insurance tax, Cadillac tax and medical device tax.

Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.

Advocates applauded its demise Friday, Dec. 20, following the president’s final pen stroke. 

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.